Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites

被引:146
作者
Hong, J
Lambert, JD
Lee, SH
Sinko, PJ
Yang, CS [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
关键词
EGCG; efflux; Pgp; MRP; MDCKII cell;
D O I
10.1016/j.bbrc.2003.09.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(-)-Epigallocatechin-3-gallate (EGCG), a major polyphenol of green tea, has many interesting biological activities. The uptake of EGCG and involvement of specific efflux pumps were studied in MDCKII cells transfected with hPgp, hMRP1, and hMRP2 genes. Total cell associated [H-3]EGCG increased 7-fold in the presence of the MRP inhibitors, indomethacin and probenecid, in MDCKII/MRP1 cells, compared to a 2-fold increase in wild-type cells. Intracellular levels of EGCG, 4"-O-methyl EGCG, and 4',4"-di-O-methyl EGCG were increased by 13-, 11-, and 3-fold, respectively, by indomethacin in MDCKII/MRP1 cells. Accumulation of EGCG and its methyl metabolites was also increased similar to10-fold in the presence of MK-571 in MDCKII/MRP2 cells. Co-treatment with isoflavones, curcumin and tetrahydrocurcumin, increased [H-3]EGCG accumulation significantly in MDCKII/MRP1 and HT-29 cells. The results indicate that EGCG and its methyl metabolites are substrates for MRP1 and MRP2, but not for Pgp. MRP type efflux pumps may limit the bioavailability of EGCG. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:222 / 227
页数:6
相关论文
共 27 条
[11]   Glucuronides of tea catechins: Enzymology of biosynthesis and biological activities [J].
Lu, H ;
Meng, XF ;
Li, C ;
Sang, SM ;
Patten, C ;
Sheng, SQ ;
Hong, JG ;
Bai, NS ;
Winnik, B ;
Ho, CT ;
Yang, CS .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (04) :452-461
[12]   Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate [J].
Lu, H ;
Meng, XF ;
Yang, CS .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) :572-579
[13]  
Masuda M, 2001, CLIN CANCER RES, V7, P4220
[14]  
Masuda Muneyuki, 2002, J Exp Ther Oncol, V2, P350, DOI 10.1046/j.1359-4117.2002.01062.x
[15]   Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats [J].
Meng, XF ;
Sang, SM ;
Zhu, NQ ;
Lu, H ;
Sheng, SQ ;
Lee, MJ ;
Ho, CT ;
Yang, CS .
CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (08) :1042-1050
[16]   Telomerase inhibition, telomerase shortening, and senescence of cancer cells by tea catechins [J].
Naasani, I ;
Seimiya, H ;
Tsuruo, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) :391-396
[17]   Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo [J].
Nam, S ;
Smith, DM ;
Dou, QP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :13322-13330
[18]   No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers [J].
Princen, HMG ;
van Duyvenvoorde, W ;
Buytenhek, R ;
Blonk, C ;
Tijburg, LBM ;
Langius, JAE ;
Meinders, AE ;
Pijl, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) :833-841
[19]  
Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164
[20]   Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2 [J].
Vaidyanathan, JB ;
Walle, T .
PHARMACEUTICAL RESEARCH, 2001, 18 (10) :1420-1425